Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|June 25, 2013
Essential requirements of zoledronate-induced cytokine and γδ T cell proliferative responsesOliver Nussbaumer, Georg Gruenbacher, Hubert Gander, et al.
Journal of Clinical Immunology|December 29, 2004
Monitoring of CD4+ and CD8+ T-cell responses after dendritic cell-based immunotherapy using CFSE dye dilution analysisThomas Putz, Reinhold Ramoner, Hubert Gander, et al.
Blood|October 21, 2004
Dendritic-cell activation by secretory phospholipase A2Reinhold Ramoner, Thomas Putz, Hubert Gander, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2008
Serum antibodies against Saccharomyces cerevisiae: a new prognostic indicator in metastatic renal-cell carcinomaReinhold Ramoner, Andrea Rahm, Hubert Gander, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2012
Quality of life during dendritic cell vaccination against metastatic renal cell carcinomaNicolai Leonhartsberger, Reinhold Ramoner, Claudia Falkensammer, et al.
Cancer Immunology, Immunotherapy : CII|September 2, 2006
Bee venom secretory phospholipase A2 and phosphatidylinositol-homologues cooperatively disrupt membrane integrity, abrogate signal transduction and inhibit proliferation of renal cancer cellsThomas Putz, Reinhold Ramoner, Hubert Gander, et al.
Frontiers in Immunology|August 27, 2019
The Human G Protein-Coupled ATP Receptor P2Y11 Is Associated With IL-10 Driven Macrophage DifferentiationGeorg Gruenbacher, Hubert Gander, Andrea Rahm, et al.
Cancer Immunology, Immunotherapy : CII|November 16, 2006
Antigen-independent immune responses after dendritic cell vaccinationNicolai Leonhartsberger, Reinhold Ramoner, Thomas Putz, et al.
Cancer Immunology, Immunotherapy : CII|December 23, 2016
Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancerRenate Pichler, Georg Gruenbacher, Zoran Culig, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 2006
IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responsesClaudia Falkensammer, Karin Jöhrer, Hubert Gander, et al.
Pageof 3